Drug Profile
Antibody guided enzyme nitrile therapy
Alternative Names: AGENT; Antibody-guided enzyme nitrile therapyLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 07 Mar 2003 Antisoma is no longer actively involved with this programme
- 13 Sep 2000 Preclinical development for Cancer in United Kingdom (Unknown route)